vs
Side-by-side financial comparison of HALOZYME THERAPEUTICS, INC. (HALO) and Tecnoglass Inc. (TGLS). Click either name above to swap in a different company.
HALOZYME THERAPEUTICS, INC. is the larger business by last-quarter revenue ($451.8M vs $245.3M, roughly 1.8× Tecnoglass Inc.). Tecnoglass Inc. runs the higher net margin — 10.6% vs -31.3%, a 42.0% gap on every dollar of revenue. On growth, HALOZYME THERAPEUTICS, INC. posted the faster year-over-year revenue change (51.6% vs 2.4%). HALOZYME THERAPEUTICS, INC. produced more free cash flow last quarter ($217.6M vs $11.4M). Over the past eight quarters, HALOZYME THERAPEUTICS, INC.'s revenue compounded faster (51.9% CAGR vs 12.8%).
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
Tecnoglass Inc. is a leading manufacturer of high-performance architectural glass, aluminum windows, doors, and associated building components. It primarily caters to residential and commercial construction sectors across North America and Latin America, offering custom, energy-efficient solutions for new construction and renovation projects.
HALO vs TGLS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $451.8M | $245.3M |
| Net Profit | $-141.6M | $26.1M |
| Gross Margin | 82.6% | 40.0% |
| Operating Margin | -20.6% | 18.3% |
| Net Margin | -31.3% | 10.6% |
| Revenue YoY | 51.6% | 2.4% |
| Net Profit YoY | -203.3% | -44.5% |
| EPS (diluted) | $-1.13 | $0.57 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $451.8M | $245.3M | ||
| Q3 25 | $354.3M | $260.5M | ||
| Q2 25 | $325.7M | $255.5M | ||
| Q1 25 | $264.9M | $222.3M | ||
| Q4 24 | $298.0M | $239.6M | ||
| Q3 24 | $290.1M | $238.3M | ||
| Q2 24 | $231.4M | $219.7M | ||
| Q1 24 | $195.9M | $192.6M |
| Q4 25 | $-141.6M | $26.1M | ||
| Q3 25 | $175.2M | $47.2M | ||
| Q2 25 | $165.2M | $44.1M | ||
| Q1 25 | $118.1M | $42.2M | ||
| Q4 24 | $137.0M | $47.0M | ||
| Q3 24 | $137.0M | $49.5M | ||
| Q2 24 | $93.2M | $35.0M | ||
| Q1 24 | $76.8M | $29.7M |
| Q4 25 | 82.6% | 40.0% | ||
| Q3 25 | 84.4% | 42.7% | ||
| Q2 25 | 85.8% | 44.7% | ||
| Q1 25 | 81.7% | 43.9% | ||
| Q4 24 | 85.9% | 44.5% | ||
| Q3 24 | 83.0% | 45.8% | ||
| Q2 24 | 82.9% | 40.8% | ||
| Q1 24 | 85.5% | 38.8% |
| Q4 25 | -20.6% | 18.3% | ||
| Q3 25 | 61.5% | 25.1% | ||
| Q2 25 | 62.2% | 24.0% | ||
| Q1 25 | 53.4% | 26.7% | ||
| Q4 24 | 58.9% | 28.0% | ||
| Q3 24 | 56.3% | 28.4% | ||
| Q2 24 | 50.7% | 23.3% | ||
| Q1 24 | 48.8% | 21.3% |
| Q4 25 | -31.3% | 10.6% | ||
| Q3 25 | 49.5% | 18.1% | ||
| Q2 25 | 50.7% | 17.3% | ||
| Q1 25 | 44.6% | 19.0% | ||
| Q4 24 | 46.0% | 19.6% | ||
| Q3 24 | 47.2% | 20.8% | ||
| Q2 24 | 40.3% | 15.9% | ||
| Q1 24 | 39.2% | 15.4% |
| Q4 25 | $-1.13 | $0.57 | ||
| Q3 25 | $1.43 | $1.01 | ||
| Q2 25 | $1.33 | $0.94 | ||
| Q1 25 | $0.93 | $0.90 | ||
| Q4 24 | $1.06 | $1.00 | ||
| Q3 24 | $1.05 | $1.05 | ||
| Q2 24 | $0.72 | $0.75 | ||
| Q1 24 | $0.60 | $0.63 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $133.8M | $104.1M |
| Total DebtLower is stronger | $2.1B | $174.4M |
| Stockholders' EquityBook value | $48.8M | $713.1M |
| Total Assets | $2.5B | $1.3B |
| Debt / EquityLower = less leverage | 43.89× | 0.24× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $133.8M | $104.1M | ||
| Q3 25 | $419.7M | $127.1M | ||
| Q2 25 | $61.9M | $140.9M | ||
| Q1 25 | $176.3M | $160.2M | ||
| Q4 24 | $115.8M | $137.5M | ||
| Q3 24 | $154.3M | $124.8M | ||
| Q2 24 | $187.9M | $129.5M | ||
| Q1 24 | $164.6M | $138.8M |
| Q4 25 | $2.1B | $174.4M | ||
| Q3 25 | $1.5B | $114.7M | ||
| Q2 25 | $1.5B | $110.6M | ||
| Q1 25 | $1.5B | $110.6M | ||
| Q4 24 | $1.5B | $111.1M | ||
| Q3 24 | $1.5B | $126.8M | ||
| Q2 24 | $1.5B | $144.7M | ||
| Q1 24 | $1.5B | $160.9M |
| Q4 25 | $48.8M | $713.1M | ||
| Q3 25 | $503.9M | $764.0M | ||
| Q2 25 | $332.7M | $736.0M | ||
| Q1 25 | $482.3M | $685.1M | ||
| Q4 24 | $363.8M | $631.2M | ||
| Q3 24 | $452.7M | $613.3M | ||
| Q2 24 | $289.4M | $574.8M | ||
| Q1 24 | $177.8M | $573.6M |
| Q4 25 | $2.5B | $1.3B | ||
| Q3 25 | $2.2B | $1.2B | ||
| Q2 25 | $2.1B | $1.2B | ||
| Q1 25 | $2.2B | $1.1B | ||
| Q4 24 | $2.1B | $1.0B | ||
| Q3 24 | $2.1B | $996.3M | ||
| Q2 24 | $2.0B | $942.5M | ||
| Q1 24 | $1.8B | $981.6M |
| Q4 25 | 43.89× | 0.24× | ||
| Q3 25 | 3.00× | 0.15× | ||
| Q2 25 | 4.54× | 0.15× | ||
| Q1 25 | 3.13× | 0.16× | ||
| Q4 24 | 4.14× | 0.18× | ||
| Q3 24 | 3.32× | 0.21× | ||
| Q2 24 | 5.19× | 0.25× | ||
| Q1 24 | 8.44× | 0.28× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $219.0M | $31.0M |
| Free Cash FlowOCF − Capex | $217.6M | $11.4M |
| FCF MarginFCF / Revenue | 48.2% | 4.7% |
| Capex IntensityCapex / Revenue | 0.3% | 8.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | $644.6M | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $219.0M | $31.0M | ||
| Q3 25 | $178.6M | $40.0M | ||
| Q2 25 | $99.7M | $17.9M | ||
| Q1 25 | $154.2M | $46.9M | ||
| Q4 24 | $178.5M | $61.1M | ||
| Q3 24 | $115.4M | $41.5M | ||
| Q2 24 | $55.8M | $34.5M | ||
| Q1 24 | $129.4M | $33.4M |
| Q4 25 | $217.6M | $11.4M | ||
| Q3 25 | $175.6M | $21.2M | ||
| Q2 25 | $98.1M | $-14.7M | ||
| Q1 25 | $153.3M | $16.5M | ||
| Q4 24 | $175.4M | $35.4M | ||
| Q3 24 | $113.9M | $17.8M | ||
| Q2 24 | $53.2M | $14.2M | ||
| Q1 24 | $125.9M | $23.6M |
| Q4 25 | 48.2% | 4.7% | ||
| Q3 25 | 49.6% | 8.2% | ||
| Q2 25 | 30.1% | -5.7% | ||
| Q1 25 | 57.9% | 7.4% | ||
| Q4 24 | 58.9% | 14.8% | ||
| Q3 24 | 39.3% | 7.5% | ||
| Q2 24 | 23.0% | 6.5% | ||
| Q1 24 | 64.3% | 12.2% |
| Q4 25 | 0.3% | 8.0% | ||
| Q3 25 | 0.9% | 7.2% | ||
| Q2 25 | 0.5% | 12.7% | ||
| Q1 25 | 0.4% | 13.7% | ||
| Q4 24 | 1.0% | 10.7% | ||
| Q3 24 | 0.5% | 9.9% | ||
| Q2 24 | 1.1% | 9.2% | ||
| Q1 24 | 1.8% | 5.1% |
| Q4 25 | — | 1.19× | ||
| Q3 25 | 1.02× | 0.85× | ||
| Q2 25 | 0.60× | 0.41× | ||
| Q1 25 | 1.31× | 1.11× | ||
| Q4 24 | 1.30× | 1.30× | ||
| Q3 24 | 0.84× | 0.84× | ||
| Q2 24 | 0.60× | 0.98× | ||
| Q1 24 | 1.68× | 1.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HALO
| Royalty | $258.0M | 57% |
| Products | $122.7M | 27% |
| Proprietary Products Sales | $59.6M | 13% |
| Device Partnered Products | $12.9M | 3% |
TGLS
| Product Sales | $164.2M | 67% |
| Fixed Price Contracts | $81.1M | 33% |
| Related Party | $692.0K | 0% |
